Developing a Clear Path Forward for Non-Clear-Cell Renal Carcinoma

被引：2
|
作者：
Pal, Sumanta K. [1 ]
Karam, Jose A. [2 ]
Bergerot, Paulo [3 ]
Agarwal, Neeraj [4 ]
机构：
[1] City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Fed Sao Paulo, Sao Paulo, Brazil
[4] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 32期
关键词：
PHASE-II; OPEN-LABEL; EVEROLIMUS; BEVACIZUMAB; TRIAL; MULTICENTER; MUTATIONS; THERAPY; MTOR; MET;
D O I：
10.1200/JCO.2016.69.3572
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：3825 / +
页数：3
相关论文
共 50 条
  • [1] Chemotherapy for non-clear-cell renal cell carcinoma
    David, Kevin A.
    Milowsky, Matthew I.
    Nanus, David M.
    CLINICAL GENITOURINARY CANCER, 2006, 4 (04) : 263 - 268
  • [2] Combination therapies in non-clear-cell renal cell carcinoma
    Aslan, Volkan
    Ozdemir, Nuriye
    Yazici, Ozan
    Ozet, Ahmet
    LANCET ONCOLOGY, 2023, 24 (10): : E401 - E401
  • [3] Non-clear-cell renal carcinoma therapy: handle with care
    Buti, Sebastiano
    Bersanelli, Melissa
    LANCET ONCOLOGY, 2016, 17 (03): : 270 - 271
  • [4] Sunitinib versus everolimus for non-clear-cell renal cell carcinoma
    Rebecca Kelsey
    Nature Reviews Urology, 2016, 13 (3) : 124 - 124
  • [5] Comparing Everolimus to Sunitinib in Non-clear-cell Renal Cell Carcinoma
    Bex, Axel
    Ljungberg, Borje
    EUROPEAN UROLOGY, 2016, 69 (05) : 875 - 876
  • [6] A well organised effort to metastatic non-clear-cell renal cell carcinoma
    Russo, Paul
    LANCET ONCOLOGY, 2019, 20 (04): : 472 - 473
  • [7] Cabozantinib in advanced non-clear-cell renal cell carcinoma: is it the way clearer now?
    Di Pierro, Giulia
    Mini, Enrico
    Roviello, Giandomenico
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [8] Differentiation of Clear Cell and Non-clear-cell Renal Cell Carcinoma through CT-based Radiomics Models and Nomogram
    Cheng, Delu
    Abudikeranmu, Yeerxiati
    Tuerdi, Batuer
    CURRENT MEDICAL IMAGING, 2023, 19 (09) : 1005 - 1017
  • [9] Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC)
    Aizer, Ayal A.
    Urun, Yuksel
    McKay, Rana R.
    Kibel, Adam S.
    Nguyen, Paul L.
    Choueiri, Toni K.
    BJU INTERNATIONAL, 2014, 113 (5B) : E67 - E74
  • [10] Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study
    Chanza, Nieves Martinez
    Xie, Wanling
    Bilen, Mehrnet Asim
    Dzimitrowicz, Hannah
    Burkart, Jarred
    Geynisman, Daniel M.
    Balakrishnan, Archana
    Bowman, I. Alex
    Jain, Rohit
    Stadler, Walter
    Zakharia, Yousef
    Narayan, Vivek
    Beuselinck, Benoit
    McKay, Rana R.
    Tripathi, Abhishek
    Pachynski, Russell
    Hahn, Andrew W.
    Hsu, JoAnn
    Shah, Sumit A.
    Lam, Elaine T.
    Rose, Tracy L.
    Mega, Anthony E.
    Vogelzang, Nicholas
    Harrison, Michael R.
    Mortazavi, Amir
    Plimack, Elizabeth R.
    Vaishampayan, Ulka
    Hammers, Hans
    George, Saby
    Haas, Naomi
    Agarwal, Neeraj
    Pal, Sumanta K.
    Srinivas, Sandy
    Carneiro, Benedito A.
    Heng, Daniel Y. C.
    Bosse, Dominick
    Choueiri, Toni K.
    Harshman, Lauren C.
    LANCET ONCOLOGY, 2019, 20 (04): : 581 - 590
12345